Jacob A Orville Exact Sciences Corp (EXAS) insider trading activity

Jacob A Orville is EVP, GM, Screening of EXACT SCIENCES CORP. Currently has a direct ownership of 25,402 shares of EXAS, which is worth approximately $1.14 Million. The most recent transaction as insider was on Feb 28, 2025, when has been sold 4,547 shares (Common Stock) at a price of $47.82 per share, resulting in proceeds of $217,437. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 25.4K

75.91% 3M change

77.34% 12M change

Total Value Held $1.14 Million

JACOB A ORVILLE Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Feb 28 2025	SELL Payment of exercise price or tax liability	$217,437 $47.82 p/Share	4,547 Reduced 15.18%	25,402 Common Stock
Feb 28 2025	BUY Exercise of conversion of derivative security	-	9,673 Added 25.86%	27,728 Common Stock
Feb 25 2025	SELL Payment of exercise price or tax liability	$95,329 $51.28 p/Share	1,859 Reduced 8.4%	20,277 Common Stock
Feb 25 2025	BUY Exercise of conversion of derivative security	-	3,954 Added 15.16%	22,136 Common Stock
Feb 20 2025	SELL Payment of exercise price or tax liability	$112,318 $50.48 p/Share	2,225 Reduced 10.9%	18,182 Common Stock
Feb 20 2025	BUY Grant, award, or other acquisition	-	4,805 Added 19.06%	20,407 Common Stock
Feb 19 2025	SELL Payment of exercise price or tax liability	$53,898 $49.63 p/Share	1,086 Reduced 6.51%	15,602 Common Stock
Feb 19 2025	BUY Exercise of conversion of derivative security	-	2,248 Added 11.87%	16,688 Common Stock
May 01 2024	SELL Open market or private sale	$6,135 $60.15 p/Share	102 Reduced 0.7%	14,440 Common Stock
Apr 30 2024	BUY Grant, award, or other acquisition	-	218 Added 1.48%	14,542 Common Stock
Mar 01 2024	SELL Open market or private sale	$127,775 $59.32 p/Share	2,154 Reduced 13.07%	14,324 Common Stock
Feb 29 2024	BUY Exercise of conversion of derivative security	-	4,724 Added 22.28%	16,478 Common Stock
Feb 27 2024	SELL Open market or private sale	$106,896 $56.89 p/Share	1,879 Reduced 13.78%	11,754 Common Stock
Feb 26 2024	BUY Exercise of conversion of derivative security	-	3,954 Added 22.48%	13,633 Common Stock
Feb 22 2024	SELL Open market or private sale	$60,557 $59.78 p/Share	1,013 Reduced 9.47%	9,679 Common Stock
Feb 21 2024	SELL Open market or private sale	$66,297 $61.5 p/Share	1,078 Reduced 11.07%	8,658 Common Stock
Feb 21 2024	BUY Grant, award, or other acquisition	-	2,034 Added 15.98%	10,692 Common Stock
Feb 20 2024	BUY Exercise of conversion of derivative security	-	2,248 Added 18.76%	9,736 Common Stock
Feb 15 2024	SELL Open market or private sale	$59,341 $61.43 p/Share	966 Reduced 11.43%	7,488 Common Stock
Feb 14 2024	BUY Exercise of conversion of derivative security	-	2,031 Added 19.37%	8,454 Common Stock
May 10 2023	SELL Open market or private sale	$400,000 $80.0 p/Share	5,000 Reduced 43.77%	6,423 Common Stock
Mar 03 2023	SELL Open market or private sale	$325,000 $65.0 p/Share	5,000 Reduced 30.45%	11,423 Common Stock
Feb 28 2023	SELL Open market or private sale	$413,677 $60.55 p/Share	6,832 Reduced 29.38%	16,423 Common Stock
Feb 27 2023	BUY Exercise of conversion of derivative security	-	3,954 Added 14.53%	23,255 Common Stock
Feb 22 2023	SELL Open market or private sale	$169,971 $62.72 p/Share	2,710 Reduced 12.31%	19,301 Common Stock

JAO

Jacob A Orville

EVP, GM, Screening

Madison, WI

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells EXAS shares.

Notify only if

Value

Insider Trading

Get notified when an Exact Sciences Corp insider buys or sells EXAS shares.

Notify only if

Operation

Value

Type

News

Receive news related to EXACT SCIENCES CORP

Track Activities on EXAS

Account